CC1C(=O)OC2C(O)C34C5OC(=O)[C@@]3(OC3OC(=O)[C@H](O)[C@]34C(C(C)(C)C)C5O)[C@]12O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?